Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with a high risk of recurrence even after successful initial treatment.

Hormone replacement therapy (HRT) may reduce the risk of dementia, particularly for certain groups of women - according to a study from the University of East Anglia and the University…

A mother's obesity during pregnancy may send molecular signals across the placenta that permanently alter her son's liver metabolism, according to a new study in mice published in Nature Communications.

Experts at the University of Sydney have found that a gene involved in regulating the body's response to stress switches on more easily in the brains of people who live…

A new study from the University of Oulu suggests that gut bacteria may send different biological signals in Parkinson’s disease.

Breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death among women globally, accounting for nearly 2.3 million new cases and 670,000 deaths in 2022…

Lung cancer is the leading cause of cancer-related death both globally and in China, accounting for roughly 40% of the world's lung cancer deaths in 2022—a disproportionate burden given that…

A WEHI-led project has received $7 million in Australian Government funding to expand the nation’s drug discovery capabilities and accelerate the translation of breakthrough research into new therapies.

Obesity and eating disorders have traditionally been treated as separate areas of healthcare – but the rapid rise of GLP-1 medicines is increasingly bringing the two together.

Wiley, a global leader in authoritative content and research intelligence, today announced the launch of its spectral analysis application programming interface (API) portfolio, providing users with a new, faster way…